Tags

Type your tag names separated by a space and hit enter

Treatment of COVID-19: a review of current and prospective pharmacotherapies.
Br J Hosp Med (Lond). 2021 Mar 02; 82(3):1-9.BJ

Abstract

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread and have grave health and socioeconomic consequences worldwide. Researchers have raced to understand the pathophysiological mechanisms underpinning the disease caused by SARS-CoV-2 so that effective therapeutic targets can be discovered. This review summarises the key pharmacotherapies that are being investigated for treatment of COVID-19, including antiviral, immunomodulator and anticoagulation strategies.

Authors+Show Affiliations

Department of General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.Department of Rheumatology and General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK. Division of Medicine, University College London, London, UK.Department of Clinical Haematology, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.Department of Respiratory Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.Department of Intensive Care, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

33792391

Citation

Quek, Eleanor, et al. "Treatment of COVID-19: a Review of Current and Prospective Pharmacotherapies." British Journal of Hospital Medicine (London, England : 2005), vol. 82, no. 3, 2021, pp. 1-9.
Quek E, Tahir H, Kumar P, et al. Treatment of COVID-19: a review of current and prospective pharmacotherapies. Br J Hosp Med (Lond). 2021;82(3):1-9.
Quek, E., Tahir, H., Kumar, P., Hastings, R., & Jha, R. (2021). Treatment of COVID-19: a review of current and prospective pharmacotherapies. British Journal of Hospital Medicine (London, England : 2005), 82(3), 1-9. https://doi.org/10.12968/hmed.2021.0112
Quek E, et al. Treatment of COVID-19: a Review of Current and Prospective Pharmacotherapies. Br J Hosp Med (Lond). 2021 Mar 2;82(3):1-9. PubMed PMID: 33792391.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Treatment of COVID-19: a review of current and prospective pharmacotherapies. AU - Quek,Eleanor, AU - Tahir,Hasan, AU - Kumar,Poornima, AU - Hastings,Robert, AU - Jha,Rajeev, Y1 - 2021/03/12/ PY - 2021/4/1/entrez PY - 2021/4/2/pubmed PY - 2021/4/13/medline KW - Anticoagulation KW - Antivirals KW - COVID-19 KW - Immunomodulator SP - 1 EP - 9 JF - British journal of hospital medicine (London, England : 2005) JO - Br J Hosp Med (Lond) VL - 82 IS - 3 N2 - The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread and have grave health and socioeconomic consequences worldwide. Researchers have raced to understand the pathophysiological mechanisms underpinning the disease caused by SARS-CoV-2 so that effective therapeutic targets can be discovered. This review summarises the key pharmacotherapies that are being investigated for treatment of COVID-19, including antiviral, immunomodulator and anticoagulation strategies. SN - 1750-8460 UR - https://www.unboundmedicine.com/medline/citation/33792391/Treatment_of_COVID_19:_a_review_of_current_and_prospective_pharmacotherapies_ DB - PRIME DP - Unbound Medicine ER -